19.04.2023 • NewsVersaliselastomersthermoplastic

Versalis Expands Elastomers at Ravenna

Versalis is planning a project at its site in Ravenna, Italy, to increase capacity for elastomers. Estimated investment costs are put at about $80 million

© Getty Images/ronfullhd
© Getty Images/ronfullhd

The aim is to further expand the production mix for highly specialized elastomers, especially thermoplastic rubbers, polybutadiene and SBR, intended for the rapidly developing tire and automotive industries.

The Milan-based company has already applied for approval from the Ministry of Environment and Energy Security in order to start on the project’s execution phase.

Adriano Alfani, Versalis CEO, said the investment “is part of the broader specialization strategy of our portfolio, accelerates the development of high-performance products and for sustainable mobility,” as well as strengthening its presence in Ravenna.

In addition to producing monomers and elastomers, Versalis also has a specialist research center at the site dedicated to various projects, including developing rubbers with renewable or recycled content and new products for the high-end tire sector, with a focus on performance and sustainability.

For the period 2022-2025, Versalis plans to invest $120 million in redeveloping the Ravenna site.

Author: Elaine Burridge, Freelance Journalist

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.